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Docosahexaenoic acid (DHA, 22:6n-3) is a unique polyunsaturated fatty acid particularly
abundant in nerve cell membrane phospholipids. DHA is a pleiotropic molecule
that, not only modulates the physicochemical properties and architecture of neuronal
plasma membrane, but it is also involved in multiple facets of neuronal biology,
from regulation of synaptic function to neuroprotection and modulation of gene
expression. As a highly unsaturated fatty acid due to the presence of six double
bonds, DHA is susceptible for oxidation, especially in the highly pro-oxidant environment
of brain parenchyma. We have recently reported the ability of DHA to regulate the
transcriptional program controlling neuronal antioxidant defenses in a hippocampal cell
line, especially the glutathione/glutaredoxin system. Within this antioxidant system, DHA
was particularly efficient in triggering the upregulation of Gpx4 gene, which encodes
for the nuclear, cytosolic, and mitochondrial isoforms of phospholipid-hydroperoxide
glutathione peroxidase (PH-GPx/GPx4), the main enzyme protecting cell membranes
against lipid peroxidation and capable to reduce oxidized phospholipids in situ. We
show here that this novel property of DHA is also significant in the hippocampus of
wild-type mice and, to a lesser extent in APP/PS1 transgenic mice, a familial model
of Alzheimer’s disease. By doing this, DHA stimulates a mechanism to self-protect from
oxidative damage even in the neuronal scenario of high aerobic metabolism and in the
presence of elevated levels of transition metals, which inevitably favor the generation of
reactive oxygen species. Noticeably, DHA also upregulated a Gpx4 CIRT (Cytoplasmic
Intron-sequence Retaining Transcripts), a novel Gpx4 splicing variant, harboring part of
the first intronic region, which according to the “sentinel RNA hypothesis” would expand
the ability of Gpx4 (and DHA) to provide neuronal antioxidant defense independently of
conventional nuclear splicing in cellular compartments, like dendritic zones, located away
from nuclear compartment. We discuss here, the crucial role of this novel transcriptional
regulation triggered by DHA in the context of normal and pathological hippocampal cell.
Keywords: docosahexaenoic acid, hippocampal cells, glutathione peroxidase 4, phospholipid-hydroperoxide
glutathione peroxidase, transcriptional regulation, intron retention, neuroprotection
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Introduction
Docosahexaenoic acid (DHA) is the most abundant n-3 long-
chain polyunsaturated fatty acid (LCPUFA) in nerve cells. In
fact, brain is the organ containing the largest amount of DHA in
the whole organism, and it seems that it was selected soon in the
evolution of the cephalization process of vertebrates to provide a
special biochemical microenvironment to nerve cell membranes,
especially during the massive accretion in the evolution of
primate brains (Crawford et al., 1999, 2013; Simopoulos, 2011).
DHA is a pleiotropic molecule; it is an essential component
of nerve cells membranes where it esterify sn-2 position of
glycerophospholipids (mainly phosphatidylethanolamine and
phosphatidylserine, the most abundant phospholipids in
nerve cells) and is largely determinant of the structural and
physicochemical properties of plasma membrane. Indeed,
properties like membrane viscosity, lateral mobility, phase
separation and microdomain segregation, conformational
transitions and stability of membrane proteins, lipid-protein
and protein-protein interactions, all have been shown to be
modulated by DHA (Uauy et al., 2001; Stillwell and Wassal,
2003; Díaz et al., 2012, 2015). Besides its structural role, DHA
participates in the modulation of neurogenesis, synaptogenesis
and neurite outgrowth, refinement of synaptic connectivity,
neurotransmitter release, and inmemory consolidation processes
(Alessandri et al., 2004; Calderon and Kim, 2004; Innis, 2007;
Cao et al., 2009; Moriguchi et al., 2013), but also in the activation
of signaling pathways for neuronal survival against oxidative and
inflammatory cascades (Oster and Pillot, 2010; Bazinet and Layé,
2014). The importance of DHA for brain health is highlighted by
the extensive epidemiological and experimental evidence linking
its depletion with the development of neurodegenerative diseases
(Huang, 2010; Díaz and Marín, 2013).
The Pro-oxidant Environment of Brain and
Lipid Peroxidation
Chemically, DHA is a 22 carbon atoms fatty acid containing
six double bonds. The presence of a double bond in the fatty
acid weakens the C–H bonds on the carbon atom nearby the
double bond and thus facilitates H• abstraction from amethylene
group, giving rise to an unpaired electron on the carbon
(–•CH–) susceptible for oxidation. This circumstance is likely
to be favored in the brain parenchyma given its high metabolic
rate and elevated oxygen consumption, which inevitably will
produce significant amounts of reactive oxygen species as by-
products, including the highly reactive superoxide anion O−2 that
is converted to H2O2 (Dröge, 2002). In addition, brain is rich
in redox transition metals, particularly iron, which by virtue
of Fenton reaction with endogenous H2O2 produce iron(III)
and generate the highly reactive hydroxyl radical OH• at the
expense of endogenous reducing agents, i.e., polyunsaturated
fatty acids like DHA or arachidonic acid, generating lipoperoxyl
radicals. Lipid peroxidation generates hydroperoxides as well
as endoperoxides, which undergo fragmentation to produce a
broad range of reactive intermediates called reactive carbonyl
species (RCS) such as isoprostanes (IsoPs), neuroprotanes,
malondialdehyde, unsaturated aldehydes including 4-hydroxy-
2-trans-nonenal (HNE), 4-hydroxy-2-trans-hexenal (HHE), and
2-propenal (acrolein), with different degrees of reactivity (Porter
et al., 1995; Niki et al., 2005; Catalá, 2009; Fritz and Petersen,
2013; Naudí et al., 2013).
Clearly, the concurrency of these factors in the presence of
high amounts of polyunsaturated fatty acids, mainly DHA, is
expected to favor the free radical-induced peroxidation of DHA
in the brain parenchyma (Van Kuijk et al., 1990; Dröge, 2002;
Valko et al., 2007). An important aspect of lipid peroxidation
is its self-propagating nature and fundamentally different from
other forms of free radical injury in that it is a self-sustaining
process capable to provoke extensive brain tissue damage (Catalá,
2009; Singh et al., 2010). As most lipids in the brain are
contained in the membrane phospholipids, the main outcome
of lipid peroxidation is the structural damage of membranes,
causing structural changes that impact membrane fluidity and
permeability, neurotransmission, signaling, ion transport, and
impaired electrical conduction.
Nerve cells are endowed with different antioxidant systems
that render them protected from oxidative damage caused by
lipid peroxides. This protection is mainly accomplished by
phase II detoxifying enzymes belonging to two antioxidant
systems, namely thioredoxin and glutathione systems, which
use hydrophilic thiol-containing molecules (thioredoxin and
glutathione, respectively), as electron donors to generate
conjugated metabolites (Arnér and Holmgren, 2000; Imai
and Nakagawa, 2003). However, although members of the
thioredoxin system (mammalian thioredoxin reductases) are
capable to reduce some non-disulfide-containing molecules,
including lipid hydroperoxides independently of thioredoxin
(Björnstedt et al., 1995), it is the only within the glutathione
system where enzymes exist that are capable to recover oxidized
membrane lipids (Imai and Nakagawa, 2003).
Phospholipid-hydroperoxide Glutathione
Peroxidase and Membrane Protection
Phospholipid hydroperoxide glutathione peroxidase, glutathione
peroxidase 4, or GPx4, is a member of glutathione peroxidases
family of selenoproteins, most of which bear a selenocystein as
catalytically active amino acid, which confers a more efficient
reaction with peroxide substrates (Nauser et al., 2006). GPx4 uses
preferentially glutathione as electron donors as long as cellular
concentrations of the reduced form (GSH) are not limiting, but
may accept other thiol groups in proteins as reducing equivalent
(Godeas et al., 1997). Therefore, GPx4 can either act as a GSH
peroxidase or a thiol peroxidase depending on the availability
of GSH (Brigelius-Flohé and Maiorino, 2013). However, unlike
other glutathione peroxidases, GPx4 is capable of reducing
complex lipid peroxides, like phospholipid hydroperoxides, even
when integrated in highly structured lipid-protein assemblies
such as lipoproteins and membranes (Imai and Nakagawa,
2003). X-ray data indicated that, in contrast to other GPx
isoforms, the active site of GPx4 lacks a surface-exposed loop
domain which appears to limit the accessibility of large oxidized
substrates, but instead contains a large hydrophobic surface
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that allows GPx4 to closely associate with membranes and
lipoproteins (Scheerer et al., 2007). Its ability to directly reduce
phospholipid hydroperoxides inmembranes without prior action
of phospholipase A2 membrane makes GPx4 unique amongst
antioxidative enzymes (Imai et al., 2003; Savaskan et al., 2007).
Further, unlike other glutathione peroxidases (GPx1, GPx2,
GPx3, GPx5, and GPx6) which exist as homo(tetra)-oligomeric
proteins, GPx4 is a monomeric protein of about 20 kDa and
misses the tetramer interfaces for oligomer formation (Scheerer
et al., 2007; Brigelius-Flohé and Maiorino, 2013).
GPx4 is also peculiar amongst glutathione peroxidases
because of its additional regulatory functions. Thus, GPx4 is
considered not only a phase II antioxidant enzyme but is
also endowed with functions associated with the regulation
of apoptosis, gene expression, eicosanoid biosynthesis, and
embryo development (Imai and Nakagawa, 2003; Savaskan
et al., 2007; Ufer and Wang, 2011). The essential nature of
GPX4 is demonstrated by the fact that genetic disruption of
the entire Gpx4 gene in homozygous Gpx4 knockout causes
in utero fetal death by midgestation (Imai et al., 2003; Yant
et al., 2003). This intrauterine lethality has been related to
increased apoptosis and cell death leading to malformation of
embryonic structures and major defects in brain development
(Imai et al., 2003; Yant et al., 2003). This contrasts profoundly
with the knockouts on Gpx1–3 genes, which are viable though
more sensitive to stressors (Brigelius-Flohé and Maiorino, 2013),
indicating a degree of redundancy of these genes for at least
some of their biochemical functions, i.e., oxidant scavengers,
in vivo.
In mammalian cells GPx4 is found in the cytoplasm, nucleus,
mitochondria, and also in the endoplasmic reticulum (Imai and
Nakagawa, 2003). From the molecular point of view, GPX4 is
also singular because the three isoenzymes, namely cytosolic
GPx4 (c-GPx4), mitochondrial GPx4 (m-GPx4), and nuclear
GPx4 (n-GPx4), all derive from a single gene (Figure 1), but that
can be distinguished by their N-terminal sequences (Imai and
Nakagawa, 2003; Savaskan et al., 2007). TheGpx4 gene comprises
7 exons, of which exons 2–7 encoding for the functional enzyme
are shared by the three isoforms. The differential N-terminal
sequences are attained by three major start sites for translation
(Figure 1) that reside in two alternative exons 1 (E1a and E1b).
Thus, exon 1a contains two in-frame translational start sites
(5′AUG and 3′AUG) separated by a sequence that encode for
a mitochondrial leader peptide. Translation initiation at the
5′AUG results in the generation of m-GPx4 isoenzyme, while
translation from the 3′AUG, that lacks this leader signal, yields
c-GPx4. Because the mitochondrial leader peptide is cleaved off
after import into mitochondria, c-GPx4 and m-GPx4 cannot be
differentiated on the basis of their primary structure. Finally,
the alternative first exon (E1b) encodes the N-terminal part of
the nuclear isoform, n-GPx4, and contains a nuclear targeting
sequence which is apparently retained after nuclear import
(Pfeifer et al., 2001), and makes this isoform distinguishable from
m/c-GPx4 at protein level.
Unexpected DHA-induced Transcriptional
Regulation of Gpx4 Gene
We have recently reported that DHA upregulates
several members of both glutathione/glutaredoxin and
thioredoxin/peroxiredoxin antioxidant systems in mouse
hippocampal HT22 cells (Casañas-Sánchez et al., 2014).
Noticeably, within the glutathione/glutaredoxin system, largest
FIGURE 1 | Structural organization of mouse Gpx4 gene. Boxes indicate coding exons (red) and UTRs (orange). Bold lines represent intronic sequences. Sites
targeted by amplification primers are shown as arrowed lines.
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changes in gene expression were observed for the Gpx4 isoforms,
around 150%, and affecting all transcripts analyzed, including
the mitochondrial, cytosolic, and nuclear isoforms. The change
induced by DHA on glutathione peroxidase genes was specific
for Gpx4 since no variation was observed for the cytosolic Gpx1
gene (Casañas-Sánchez et al., 2014). Paralleling these changes,
DHA treatment significantly increased GPx4 (and total GPx)
activities, following a time-course that was compatible with
the necessary delay for Gpx4 mRNA translation. Importantly,
these effects of DHA were specific for DHA and were not be
detected when DHA was replaced by arachidonic acid, another
highly abundant polyunsaturated fatty acid in nerve cells, under
identical experimental conditions (Casañas-Sánchez et al., 2014).
Absolute quantification of Gpx4 isoform expression in
unstimulated HT22 cells revealed that the largest expression
values corresponded to the cytoplasmic variant and the lowest
for the nuclear mRNA variant, with a difference of about 3
orders of magnitude (Figure 2). Furthermore, in absolute terms,
we observed that DHA treatment increases nearly 1.5-fold the
expression of m/c-Gpx4, which must be attributable to the
enhancement of the mRNA coding for the cytoplasmic isoform,
whose abundance is about one order of magnitude higher than
for m-Gpx4. The nuclear isoform was also up-regulated by DHA,
but its absolute magnitude was negligible compared to m/c-Gpx4
(Figure 2).
Using identical amplicons (Table 1), we further explored for
the presence of these differentGpx4 isoforms in the hippocampus
of C57BL/6 mice. The results revealed the presence of all
different isoforms, and noticeably, following a similar expression
pattern, with m/c-Gpx4 being the most abundant transcripts
and n-Gpx4 showing lowest expression. Interestingly, animals
FIGURE 2 | Absolute quantification of Gpx4 mRNA isoforms in HT22
cells exposed to BSA (Vehicle: Bovine serum albumin) or DHA for 48h.
The normalization factor (reference mRNA) for each cDNA sample was
calculated as the geometric mean of the expression values of reference genes
Hprt1 and Tbp genes using standard curves generated from purified
amplicons as described in Expósito-Rodríguez et al. (2011). Data are
expressed as mean ± SEM from four different experiments. Statistical
comparisons were assessed using Mann-Whitney U-test for independent
samples. *p < 0.05 and **p < 0.01 compared to BSA.
exposed to High or Low-DHA diets also exhibited differential
Gpx4 transcriptional regulation in response to DHA-containing
or DHA-impoverished diets and differentially affected between
wild-type and APP/PS1, a familial model of Alzheimer’s disease
(Figure 3). Thus, Absolute quantification of Gpx4 isoforms
in WT animals, revealed that Low-DHA diets leads to the
stimulation of gene expression of all isoforms (between 1.43
and 1.99 times), being the largest stimulation observed for the
cytosolic isoform, which, in turn is the most abundant Gpx4
isoform under any circumstance (Figure 3). These observations
strongly suggest a compensatory genetic strategy aimed to
ensure protection of membrane DHA from oxidative damage
under conditions of limited DHA availability. Overall these
data indicates that the lack of sufficient DHA or its deficient
supply is accompanied by increased Gpx4 mRNAs expression
and GPx4 protein synthesis, which consequently augment
cellular resistance to oxidative damage of DHA-containing
phospholipids. A different behavior was observed in APP/PS1
animals, where the high-DHA containing diet stimulated the
expression of cytoplasmic and mitochondrial Gpx4 mRNAs.
The different expression levels observed in APP/PS1 animals,
especially for the m-Gpx4 isoform, suggest a genotype-related
transcriptional regulation, which fits well with the increased
levels of hippocampal oxidative stress demonstrated in transgenic
animals (Aso et al., 2012) and also the lower levels of
hippocampal DHA compared to WT animals (Fabelo et al.,
2012).
Finally, using appropriate amplicons (Table 2) we tested for
the presence and absolute abundance of the different GPX4
transcripts in the human cell line SHSY-5Y. The results revealed
that all GPX4 isoforms are expressed in this cell line and, more
interestingly, that their absolute abundance followed the same
sequence observed in HT22 cells, though in this case the amount
of the most prominent isoform, namely c-GPX4, was notably
higher (about four orders of magnitude) than any other isoform.
Defining a Unified Rationale for
DHA-induced Regulation of Gpx4 Gene
Expression
Our initial observations in HT22 indicated that the upregulation
of Gpx4 expression occurred with a significant delay form the
initial exposure to DHA. Thus, it was necessary to expose cells for
48 h to detect the significant change in the expression levels of all
Gpx4 isoforms (Casañas-Sánchez et al., 2014). Our interpretation
of these findings was related to the fact that control unstimulated
HT22 cells (as most neuronal cell lines studied so far) contain
extremely low levels of DHA in their membrane phospholipids
(Martín et al., 2006). Supplementation of culture medium with
DHA causes a nearly immediate incorporation by deacylation-
reacylation mechanisms, whereby some monounsaturated fatty
acids (mainly oleic acid) are readily replaced with DHA in
membrane phospholipids (Farooqui et al., 2000; Martín et al.,
2006). The activation of the transcriptional process occurred
only after membrane phospholipids were replenished, because
only then enough DHA remained unesterified in the cytoplasm
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TABLE 1 | Oligonucleotides used as primers for quantification of different Gpx4 mRNA isoforms and for mapping 5′ end of I-Gpx4 mRNA in HT22 cells
and mouse hippocampus.
Targeted gene Primers Exon/intron Amplicon size (bp) gDNA discrimination
m-Gpx4 F-89: CCgCCgAgATgAgCTgg E1a 128 No
R112: TgCACACgAAACCCCTgTACT E2-E3
m/c-Gpx4 F-16: TggTCTggCAggCACCAT E1a 201 No
R112: TgCACACgAAACCCCTgTACT E2-E3
n-Gpx4 F240: gTTCCTgggCTTgTgTgCAT E1b-E2 140 No
R379: AggCCACgTTggTgACgAT E3
n/I-Gpx4 F205: CTgCAAgAgCCTCCCCAgT E1b 157/370 Yes
R112: TgCACACgAAACCCCTgTACT E2-E3
I-Gpx4 FI1b176: ggACCTgggTTAggACACTCA I1b 147 Yes
R112: TgCACACgAAACCCCTgTACT E2-E3
Mapping (+1) F+1: gTgggCTACTggGAACTTgg I1a 907
R112: TgCACACgAAACCCCTgTACT E2-E3
Mapping (+2) F+2: gggAAAgCggAgCCTgATAg I1a 787
R112:TgCACACgAAACCCCTgTACT E2-E3
Mapping (+3) F+3: CTTggCTACCggCTCTTTg I1a 630
R112: TgCACACgAAACCCCTgTACT E2-E3
Hprt1 F: TCAgACTgAAgAgCTACTgTAATgA E3-E4 136 Yes
R: AAgTTTgCATTgTTTTACCAgTg E6
Tbp F: gACCCACCAgCAgTTCAgTAg E6 136 Yes
R: CTCTgCTCTAACTTTAgCACCTgT E7-E8
Determination of absolute mRNA levels by real-time quantitative PCR (RT-qPCR) were performed as described in Expósito-Rodríguez et al. (2011). Hprt1, Hypoxanthine guanine
phosphoribosyl transferase 1; Tbp, TATA binding protein.
of neuronal cells, being then susceptible for non-enzymatic
oxidation in the prooxidant cellular environment (Figure 4).
Indeed we could only detect significant levels of the specific
DHA-derived lipoperoxide 4-hydroxy-2-hexenal (HHE) after
36 h exposure to DHA, just before upregulation of Gpx4
expression occurred. These findings were interpreted as HHE
providing the signal to trigger transcriptional regulation, likely
through activation of Nrf2 transcription factor. Indeed, it is
known that Nrf2 is a master factor for the regulation of
antioxidant response elements (ARE) in several antioxidant and
phase II detoxifying proteins in different cell types, including
nerve cells (Kobayashi and Yamamoto, 2005; Zhang et al., 2013),
and several reports have shown that although DHA itself does
not bind Nrf2, it may stimulate transcriptional activity of ARE-
containing genes through activation of Nrf2 upon generation
of 4-hydroxy-2-hexenal, which indeed activates Nrf2 (Ishikado
et al., 2013; Kusunoki et al., 2013; Yang et al., 2013).
The results obtained in the hippocampus of WT mice were
particularly interesting, since transcriptional activation of all
Gpx4 isoforms was significantly higher under the Low-DHA
dietary condition compared to the High-DHA diet. Though
apparently these results might contradict the results obtained
in HT22 cells, the outcomes suggest that it is under a low
DHA diet with limited availability of n-3 precursors, when it is
especially important to activate mechanisms (like upregulation
of Gpx4 isoform expression) that may ensure the preservation of
DHA in brain membranes. In fact, analyses of hippocampal lipid
composition in WT and APP/PS1 animals revealed a significant
reduction of DHA contents in Low-DHA diet compared to
the High-DHA diet, yet the amount of DHA in the Low-DHA
condition was surprisingly higher than expected from the dietary
supply (Table 3), which reflects an extremely efficient ability to
preserve brain DHA even when subjected to negligible levels
in the diet (Díaz et al., accepted). This exceptional capability is
mainly attributable to the favorable gradient for fatty acids to
cross the blood-brain barrier, either passively or via fatty acid
binding proteins (FATPs), since once in the brain, unesterified
fatty acids are converted to CoA thioesters by the long-chain-
fatty-acid-CoA synthase (ACSL) family of proteins, therefore
maintaining a continuous concentration gradient (see (Bazinet
and Layé, 2014) for comprehensive review).
As mentioned before, APP/PS1 animals also responded to
the different diets with changes in the transcriptional levels
of Gpx4 expression. However, we only observed increased
expression of c-Gpx4 isoform, and in the High-DHA diet. The
apparent discrepancy between WT and APP/PS1 animals is
likely related to the involvement of constitutive oxidative stress
associated to amyloid generation in the brain of transgenic
animals (Aso et al., 2012; Fabelo et al., 2012). Indeed, it is
now widely accepted that amyloid peptide induces oxidative
stress, and inflammation and oxidative stress generate more
Aβ, giving rise to a vicious cycle between Aβ and free
radical formation/lipid peroxidation in the presence of transition
metals (Behl et al., 1994; Pamplona et al., 2005; Solfrizzi
et al., 2006). In line with this matter, increased levels of
LCPUFA–derived lipid hydroperoxides like HHE, HNE, and
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A
B
FIGURE 3 | Absolute quantification of Gpx4 mRNA isoforms in 6
months old Wild-type (A) and APP/PS1 (B) mice fed Low-DHA or
High-DHA diets for 3 months. Data are expressed as mean ± SEM from
four different animals under each dietary condition and genotype. The
normalization factor (reference mRNA) for each cDNA sample was calculated
as the geometric mean of the expression values of reference genes Hprt1 and
Tbp genes using standard curves generated from purified amplicons as
described in Expósito-Rodríguez et al. (2011). Statistical comparisons were
assessed using Mann-Whitney U-test for independent samples. *p < 0.05,
**p < 0.01, and #p < 0.1 compared to Low-DHA.
other endoperoxides like isoprostanes have been observed in
the brain of transgenic models of Alzheimer’s disease, including
3xTgAD and APP/PS1 animals, and more relevantly, in different
areas of human brain and cerebrospinal fluid of AD patients
(Marcus et al., 1998; Markesbery and Lovell, 1998; Praticò
et al., 1998; Valko et al., 2007; Gwon et al., 2012). In this
order of ideas, it seems plausible that in the high-DHA diet,
lipid-derived hydroperoxides must be elevated in the more
prooxidant environment of brain parenchyma in transgenic
animals, including DHA-related HHE, which may trigger the
stimulation of Nrf2 transcription factor, which eventually would
favor the activation of a transcriptional program to increase
Gpx4 isoforms expression, especially the cytoplasmic isoform.
In agreement with our findings, recent genomic gene expression
profiles by microarray analyses in a “gene dose-response” model
of Nrf2-null model have revealed that graded activation of
Nrf2 increased the transcription of a large number of genes
involved in Nrf2-mediated oxidative stress response, glutathione
metabolism, and xenobiotic metabolism, including several genes
responsible for the reduction of superoxide ions using GSH, i.e.,
glutathione peroxidases Gpx2 and Gpx4, which augmented by
2260 and 105%, respectively, in Keap1-HKO mice compared to
WT mice (Wu et al., 2011).
Alternatively, altered genetic regulation of Gpx4 expression
caused by overexpression of mutated APP and PS1 in transgenic
animals, may have disturbed the normal gene expression pattern,
as it has been recently demonstrated to occur in the frontal cortex
and hippocampus of transgenic mice carrying the 1E9 mutant
hPS1 gene (Unger et al., 2005). Likewise, recent comparative
studies in sporadic (icv-STZ Mouse) and familial (3xTg-AD
mouse) mice models of AD have revealed the transcriptional
alteration of more than 80 genes related to synapse function,
apoptosis and autophagy, AD-related protein kinases, glucose
metabolism, insulin signaling, and mTOR pathway in the
hippocampus and the cerebral cortex, not only when compared
to WT animals, but also between both AD models (Chen et al.,
2012).
In summary, we hypothesize that by upregulating Gpx4 gene
expression and increasing GPx4 protein levels and enzyme
activity, DHA initiates a self-protective biochemical strategy in
the hippocampal neuron to control non-enzymatic peroxidation
of DHA-containing phospholipids in themembrane from cellular
and subcellular compartments. Given the extremely low capacity
of hippocampal cells to biosynthesize DHA (reviewed in Plourde
and Cunnane, 2007; Bazinet and Layé, 2014), and the essential
nature of this fatty acid in the nervous system, this strategy
provides an adaptive mechanism to keep the high DHA levels in
hippocampal phospholipids.
Retained Intronic Sequences in Gpx4
mRNA
In initial experimental strategy used for the detection of the
different Gpx4mRNAs, we designed a couple of primers targeted
to exons E1b (forward primer) and the boundary between exons
E2/E3 (reverse primer) for the specific detection of nuclear
Gpx4 mRNA. Unexpectedly, in these experiments we detected
the presence of two amplicons: one of the expected molecular
size (157 bp) for a fully processed n-Gpx4 mRNA, and another
fragment 370 bp. Once sequenced, we observed that this later
amplicon contained an extra 213 bp sequence corresponding to
intron I1b located between exons E1b and E2. This unexpected
sequence (named here I-Gpx4) was detected in control HT22 cells
(treated with vehicle), but more interestingly, that its expression
level was subjected to significant upregulation by DHA treatment
(near 100% compared to control cells), which was in the range
observed for the changes in expression for the set of other
Gpx4 mRNA variants (Figure 2). In absolute terms, I-Gpx4
quantification revealed that this isoform was nearly 3 times more
abundant than n-Gpx4 under unstimulated conditions, and about
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TABLE 2 | Oligonucleotides used as primers for quantification of different GPX4 mRNA isoforms and for mapping 5′ end of I-GPX4 mRNA in SHSY-5Y
cells.
Targeted gene Primers Exon/intron Amplicon Size (bp) gDNA discrimination
m-GPX4 F-E1m: CATTggTCggCTggACgAg E1a 242 Yes
R-E34: CACACgAAgCCCCggTACT E2-E3
m/c-GPX4 F-E1c: CCTggCCgggACCATg E1a 123 Yes
R-E34: CACACgAAgCCCCggTACT E2-E3
n- GPX4 F-E2si: CAggCAgCggTgCCAgAg E1b 170 Yes
R-E23: gggACgCgCACgggTC E1b-E2
n/I- GPX4 F-E2N: gATCCACgAATgTCCCAAgTC E1b 138/394 Yes
R-E34: CACACgAAgCCCCggTACT E2-E3
I- GPX4 F-I1b: gAggAgCgTTCAggTCTTCAg I1b 242 No
R-E34: CACACgAAgCCCCggTACT E2-E3
Mapping (+1) F+1: gTgAgCTAgCgCCgCg I1a 1165
R-E34: CACACgAAgCCCCggTACT E2-E3
Mapping (+2) F+2: CCCTCCAggCCgTTgTAgg I1a 978
R-E34: CACACgAAgCCCCggTACT E2-E3
Mapping (+3) F+3: CggAgggCTggAAATCCC I1a 730
R-E34: CACACgAAgCCCCggTACT E2-E3
HPRT1 F: gACCAgTCAACAggggACAT 173 Yes
R:AACACTTCgTggggTCCTTTTC
RPL32 F: CATCTCCTTCTCggCATCA 153 Yes
R:AACCCTgTTgTCAATgCCTC
Determination of absolute mRNA levels by real-time quantitative PCR (RT-qPCR) were performed as described in Expósito-Rodríguez et al. (2011). HPRT1, Hypoxanthine guanine
phosphoribosyl transferase 1; RPL32, Ribosomal protein L32.
FIGURE 4 | Schematic model depicting the hypothetical mechanism of DHA-mediated regulation of Gpx4 in HT22 cells. For details see “Defining a unified
rationale for DHA-induced regulation of Gpx4 gene expression.” Modified from Casañas-Sánchez et al. (2014).
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TABLE 3 | Fatty acid composition of total lipids in the hippocampus of 6 months old WT and APP/PS1 mice, and fed for 3 months with either Low-DHA or
High-DHA diets.
Fatty acid WT APP/PS1
Low-DHA High-DHA Low-DHA High-DHA
14: 0 0.10± 0.00*# 0.12±0.00# 0.12± 0.01 0.13± 0.00
16: 0 DMA 2.16± 0.01 2.12±0.01 2.11± 0.04 2.13± 0.04
16: 0 18.41± 0.06# 18.58±0.16 17.80± 0.16 18.25± 0.20
18: 0 DMA 4.07± 0.04 4.09±0.06 4.01± 0.15 4.04± 0.05
18:1 n-9 DMA 1.51± 0.04 1.54±0.03 1.52± 0.08 1.52± 0.06
18:1 n-7 DMA 1.94± 0.05 2.01±0.04 2.09± 0.05 1.99± 0.08
18: 0 19.60± 0.10* 19.05±0.01 19.54± 0.12 19.14± 0.30
18: 1 n-9 15.81± 0.06*# 17.04±0.11 16.32± 0.16 17.00± 0.25
18: 1 n-7 3.59± 0.06* 3.40±0.01 4.18± 0.60 4.11± 0.56
18: 2 n-6 0.49± 0.01 0.48±0.02 0.50± 0.02 0.48± 0.03
20: 0 0.28± 0.01 0.26±0.01 0.29± 0.01 0.26± 0.02
20: 1 n-9 1.76± 0.05 1.80±0.03 1.96± 0.07 1.74± 0.11
20: 1 n-7 0.34± 0.01 0.36±0.00 0.37± 0.02 0.36± 0.02
20: 3 n-6 0.28± 0.01* 0.57±0.00# 0.28± 0.01* 0.54± 0.01
21: 0 0.02± 0.01 0.00±0.00 0.00± 0.00 0.00± 0.00
20: 4 n-6 9.87± 0.16*# 7.64±0.02 9.34± 0.07* 7.54± 0.19
20:5 n-3 0.00± 0.00* 0.19±0.01 0.00± 0.00* 0.21± 0.01
22:0 0.22± 0.01 0.21±0.00 0.24± 0.01 0.21± 0.02
22: 4 n-6 3.05± 0.06* 1.85±0.02 3.14± 0.10* 1.82± 0.07
22: 5 n-6 1.19± 0.02*# 0.09±0.00 0.87± 0.04* 0.09± 0.01
22: 5 n-3 0.03± 0.01* 0.39±0.01 0.01± 0.01* 0.39± 0.01
24: 0 0.26± 0.01 0.26±0.01 0.29± 0.02 0.27± 0.03
22: 6 n-3 12.69± 0.21*# 16.66±0.101 11.19± 0.11* 15.04± 0.55
24: 1 n-9 0.85± 0.03# 0.83±0.04# 1.19± 0.09* 0.70± 0.01
TOTALS AND INDEXES
Saturates 45.35± 0.05* 44.84±0.12 44.61± 0.38 44.59± 0.49
Unsaturated 54.54± 0.05* 55.05±0.12 55.27± 0.39 55.28± 0.50
DMAs 9.67± 0.08 9.76±0.12 9.74± 0.31 9.68± 0.15
n-9 20.34± 0.18*# 21.62±0.16 21.53± 0.15 21.43± 0.56
n-3 12.80± 0.21* 16.31±0.09 11.27± 0.12* 15.16± 0.55
n-6 14.99± 0.22*# 10.70±0.04 14.23± 0.12* 10.53± 0.27
n-3/n-6 0.85± 0.02* 1.52±0.01 0.86± 0.01* 1.53± 0.03
18:1 n-9/n-3 H 1.24± 0.02*# 1.06±0.01 1.34± 0.02* 1.07± 0.06
Unsaturation Index 163.12± 0.99*# 166.48±0.30 158.64± 0.53 165.50± 2.94
saturates/n-3 3.55± 0.05* 2.75±0.01 3.64± 0.03* 2.77± 0.07
saturates/n-9 2.23± 0.02*# 2.07±0.02 2.07± 0.02 2.09± 0.07
Results are expressed as mole % and represent means ± SEM of four different animals under each dietary condition and genotype. DMA: Dimethyl acetals. *p < 0.05 compared to
High-DHA. #, 1: p < 0.05 and p < 0.1 compared to APP/PS1. Fatty acid extraction and determination was performed as described in Fabelo et al. (2012) and Martín et al. (2006).
Data were analysed by One-Way ANOVA followed by Tukey’s multiple comparison test. Comparisons between Low-DHA and High-DHA treatments were performed using Student’s
t-test or Mann-Whitney U-test where appropriate. Main monoenoic (oleic acid, 18:1n9), n-6 LCPUFA (arachidonic acid, 20:4n-6), and n-3 LCPUFA (DHA, 22:6n-3) are highlighted on
pink background.
7 times higher after DHA treatment, pointing to a significant
biological role of this intron-retaining isoform in hippocampal
cells. Nonetheless, I-Gpx4 was expressed a much lower amount
than c-Gpx4, even after DHA treatment.
In order to gain a deeper insight on the transcription start
site for the intron-retained transcript, we designed several
amplification primers directed to intron I1a (Figure 1 and
Table 1). While the primers targeted to E1b exon and intron I1b
amplified the expected amplicons, all other primers targeting E1b
exon upstream sequences were unsuccessful in these PCR assays.
These results strongly indicate that a Gpx4 CIRT transcript
represents an unprocessed variant of the n-Gpx4mRNA isoform.
In order to assess for the biological relevance of this intron-
retaining Gpx4 isoform, we used these specific amplicons to
unveil the presence in the hippocampus of C57Bl/6 mice. We
observed that not only the amplicon was detected, but also that
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its expression was modulated by the contents of DHA in the
diet. Thus, levels of I-Gpx4 isoform were significantly higher
(around 2 times) in animals receiving Low-DHA diet compared
to animals receiving a High-DHA diet. A similar result was
obtained in transgenic APP/PS1 animals, though in this case the
increase in I-Gpx4 gene expression was around 1.6 times higher
in animals maintained in a Low-DHA diet (Figure 3). Absolute
comparisons between WT and APP/PS1 animals revealed that I-
Gpx4 was higher in WT animals than in the APP/PS1 genotype.
Overall these data indicates that the lack of sufficient DHA
or its deficient supply is accompanied by an increase in I-
Gpx4. Again, these higher expression levels observed in APP/PS1
animals suggests a genotype-related transcriptional regulation,
which may be related to increased hippocampal oxidative stress
in transgenic animals (Aso et al., 2012).
Whether this regulated Gpx4 mRNA variant constitutes an
intermediate processing stage of Gpx4 splicing or represents a
different level of transcriptional regulation by intron retention
remains unrevealed. However, the notion of intron retention
has been gaining consistency in the last decade, as an
alternative processing of conventional (nuclear) mRNA, adding
a novel level of complexity in gene expression regulation.
These sequences, named as CIRTs (Cytoplasmic Intron-sequence
Retaining Transcripts), comprise only few introns and are
limited to small fractions of introns within the gene (Buckley
et al., 2014). Indeed, in recent years, a number of transcripts
containing intronic sequences and subjected to cytoplasmic
splicing have been unveiled across a number of cell types and
species (Buckley et al., 2014), and the list keeps growing steadily.
Noticeably, a recent study performed in mouse brains have
revealed the broad presence of cytoplasmic intron-sequence
retaining transcripts in hippocampal neurons, with 59.4% of
total gene transcripts in dendrites containing intronic reads
(Khaladkar et al., 2013). Examples of retained introns from
individual transcripts of relevance in neuronal cells include
the large-conductance calcium-dependent potassium channel
(BK) encoded by KCNMA1 gene (Bell et al., 2008, 2010), γ-
subunit of GABA-A receptor (encoded by GABRG3) (Buckley
et al., 2011), ionotropic Glutamate receptor (encoded by GRIK1
gene) and type 1 NMDA receptor (encoded by GRIN1)
(Buckley et al., 2011) or the α-1 subunit of T type, voltage-
dependent Calcium channel (encoded by CACNA1H) (Zhong
et al., 2006). Though the biological relevance of CIRTs is
still largely unknown, their abundance in neuronal dendrites
(and also in enucleated platelets) suggest that endogenous
cytoplasmic transcripts harboring retained intronic substrates
could be subject to extranuclear splicing, thereby obviating
the need for shuttling molecules to and from the nucleus for
processing (Buckley et al., 2014). In this manner, dendritic
splicing could represent a novel method of post-transcriptional
gene regulation.
In this order of ideas, it is tempting to speculate that CIRT
in Gpx4-I gene may be part of the normal endogenous post-
transcriptional regulation pathway. Such regulated extranuclear
splicing variants may be part of what Buckley et al. (2014)
designed as “sentinel RNA hypothesis,” according to which a
master transcript harboring CIRTs would serve to generate
transcript variants within the cytoplasm in response to specific
stimulation, or under conditions in which a rapid processing is
required and adaptive. A plausible scenario for this stimulus-
dependent cytoplasmic splicing of I-Gpx4 in hippocampal cells,
is that this transcript processing in cellular domains distant
from cellular nucleus, as is the case of dendrites, would enhance
the antioxidant buffering capacity against the acute generation
of lipid peroxides by oxidative insults, which would commit
the integrity of membrane unsaturated phospholipids, especially
those enriched in DHA.
Conclusions and Hypothesis
In summary, current available data indicate that Gpx4 gene is
subjected to a complex transcriptional regulation that renders
nuclear, cytoplasmic, and mitochondrial isoforms, but also
generate an intron-retaining variant, likely corresponding to a
CIRT, all derived from the same gene. At least in hippocampal
HT22 cells and in the hippocampus of wild type mice, the
transcriptional control of most of these Gpx4 isoforms is
modulated by DHA following an unprecedented homeostatic
strategy aimed to buffer its potential oxidation and to ensure
its preservation in the hippocampal neuronal membrane. The
observations in transgenic APP/PS1 mice, suggest that such
homeostatic mechanism is disturbed by the presence of mutated
APP and/or PS1, and may be relevant in Alzheimer’s disease, as
suggested by the generalized observation that DHA contents are
reduced in the hippocampus of AD brains.
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